Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Brukinsa
Descriptions
Zanubrutinib is used to treat mantle cell lymphoma (MCL) in adults who have received at least one previous treatment for their cancer. This medicine is also used to treat Waldenström macroglobulinemia (WM). It is also used to treat marginal zone lymphoma (MZL) that has come back (relapsed) or did not respond to the treatment (refractory) in patients who have received at least one previous treatment (eg, anti-CD20-based treatment). It interferes with the growth of cancer cells, which are eventually destroyed by the body. Zanubrutinib is an antineoplastic agent (cancer medicine).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2022
Copyright © 2022 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.